Edwards Lifesciences Corp (EW)

EW (NYSE:Health Services)
$85.00
pos +0.00
+0.00%
Today's Range: 84.68 - 85.44 | EW Avg Daily Volume: 967,300
Last Update: 07/25/14 - 4:02 PM EDT
Volume: 0
YTD Performance: 29.26%
Open: $0.00
Previous Close: $85.17
52 Week Range: $60.62 - $88.41
Oustanding Shares: 105,493,815
Market Cap: 8,984,908,224
6-Month Chart
TheStreet Ratings Grade for EW
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 10 10 9 9
Moderate Buy 0 0 0 0
Hold 5 5 5 7
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.67 1.67 1.71 1.88
Latest Dividend: 0.00
Latest Dividend Yield: 0.00%
Dividend Ex-Date: 12/31/69
Price Earnings Ratio: 30.86
Price Earnings Comparisons:
EW Sector Avg. S&P 500
30.86 31.00 28.93
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
5.59% 20.26% 14.26%
GROWTH 12 Mo 3 Yr CAGR
Revenue 7.70 0.41 0.12
Net Income 33.60 0.80 0.21
EPS 38.90 0.83 0.22
Earnings for EW:
EBITDA 0.52B
Revenue 2.05B
Average Earnings Estimates
Qtr (06/14) Qtr (09/14) FY (12/14) FY (12/15)
Average Estimate $0.77 $0.72 $3.14 $3.64
Number of Analysts 10 9 10 11
High Estimate $0.81 $0.77 $3.22 $3.90
Low Estimate $0.74 $0.66 $3.04 $3.39
Prior Year $0.82 $0.68 $3.13 $3.14
Growth Rate (Year over Year) -6.59% 6.37% 0.19% 16.19%
Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands
A wave of M&A in the health sector makes sense.
Bullish
Jun 11, 2014 | 7:57 AM EDT
EW was upgraded from Market Perform to Outperform, JMP Securities said. $97 price target. Estimates also increased, following positive ...
If you step out of the blinding spotlight, the truly rewarding buying opportunities become obvious.
Keep a tally that summarizes all your related holdings: stock, calls and puts.
Sell into the pop as the good news is set.
Bullish
Apr 14, 2014 | 8:12 AM EDT
EW was upgraded from Underweight to Neutral, JP Morgan said. $78 price target. CoreValve injunction has materially altered the industry...
Bullish
Mar 10, 2014 | 8:09 AM EDT
EW was upgraded from Market Perform to Outperform, Wells Fargo said. FIM sales should help drive near-term growth. 

Buy the Bear, Pass on the Bull Real Money Pro($)

Analyzing a pair of picks by Zacks.
The company is a steady grower, but its stock has swooned.
Bearish
Dec 10, 2013 | 7:27 AM EST
EW was downgraded from Outperform to Market Perform, Wells Fargo said. Company is facing increased domestic competition. 

Columnist Conversations

Index Chart of the Day: SPX and RUT Divergence SPX vs. RUT (YTD) View Chart »&nbs...
Is this the biotech revolution or the biotech bust? View Small Cap Biotechs Like Never Before: Transparency is...
The S&P 500 index finished the week unchanged, but the VIX was up 5%, the divergence sending a bit of a mi...
Weyerhaeuser has been struggling since testing the 2013 highs last month. The stock extended a powerful...

REAL MONEY'S BEST IDEAS

Columnist Tweets

BROKERAGE PARTNERS

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.


TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.